Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: J Neurooncol. 2019 Mar 13;143(1):137–144. doi: 10.1007/s11060-019-03147-6

Figure 1:

Figure 1:

Case example showing hematoxylin and eosin (H&E) staining as well as immunohistochemistry for progesterone receptor (PR) and estrogen receptor (ER) at 20x and 40x from a patient with a history of fertility treatment and a WHO grade 1 meningioma.